When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Graves' disease

Last reviewed: 12 Apr 2025
Last updated: 12 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • heat intolerance
  • sweating
  • weight loss
  • palpitations
  • tremor
  • diffuse goitre
  • orbitopathy
Full details

Other diagnostic factors

  • irritability
  • cardiac flow murmur
  • moist, velvety skin
  • scalp hair loss
  • muscle weakness
  • thyroid bruit
  • onycholysis
  • vitiligo
  • pretibial myxoedema
  • acropachy
  • menstrual irregularity
  • sexual dysfunction
Full details

Risk factors

  • family history autoimmune thyroid disease
  • female sex
  • tobacco use
  • high iodine intake
  • lithium therapy
  • biological agent and cytokine therapies
  • radiation
  • radioiodine therapy for benign nodular goitre
  • stress
Full details

Diagnostic investigations

1st investigations to order

  • thyroid-stimulating hormone (TSH)
  • serum free or total T4
  • serum free or total T3
  • TSH receptor antibodies (TRAb)
Full details

Investigations to consider

  • calculation of total T3/T4 or FT3/FT4 ratio
  • radioactive iodine or technetium-99 uptake
  • thyroid scan (scintigraphy)
  • thyroid peroxidase antibodies (TPOAb)
  • thyroid ultrasound
  • CT or MRI scan of orbit
  • skin biopsy
Full details

Treatment algorithm

ACUTE

thyroid storm

ONGOING

subclinical Graves' disease

symptomatic non-pregnant, non-lactating adults

pregnant women

children

Contributors

Authors

Salman Razvi, MD

Consultant Endocrinologist and Senior Lecturer

Translational and Clinical Research Institute, Queen Elizabeth Hospital, Gateshead

Newcastle University

Newcastle upon Tyne

UK

Disclosures

SR has received speaker fees from Merck, IBSA, and Abbott Pharmaceuticals Ltd., all makers of levothyroxine. In addition, SR is in receipt of funding for an investigator-initiated trial from Merck to study the role of thyroid hormones in heart failure.

Acknowledgements

Dr Salman Razvi would like to gratefully acknowledge Dr Petros Perros, Dr Douglas S. Ross, Dr George Hennemann, and Dr Vahab Fatourechi, previous contributors to this topic.

Disclosures

PP, DSR, GH, and VF are authors of references cited in this topic.

Peer reviewers

Elizabeth N. Pearce, MD

Associate Professor of Medicine

Boston University Medical Center

Boston

MA

Disclosures

ENP is a consultant for Scientific Consulting Company GmbH and a management council member for the Iodine Global Network.

Kristien Boelaert, MD, PhD, FRCP

Reader in Endocrinology

Institute of Metabolism and Systems Research

College of Medical and Dental Sciences

University of Birmingham

Birmingham

UK

Disclosures

KB declares that she has no competing interests.

Paul Carroll, MD, FRCP

Clinical Lead for Endocrinology

Chair of Thyroid MDM

Guy’s and St Thomas’ NHS Trust

London

UK

Disclosures

PC declares that he has no competing interests.

David Cooper, MD

Division Head

Endocrinology

Sinai Hospital of Baltimore

Baltimore

MD

Disclosures

DC declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2018 Jul 25;7(4):167-86.Full text  Abstract

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.Full text  Abstract

National Institute for Health and Care Excellence. Thyroid disease: assessment and management. Oct 2023 [internet publication].Full text

Mooij CF, Cheetham TD, Verburg FA, et al. 2022 European Thyroid Association guideline for the management of pediatric Graves' disease. Eur Thyroid J. 2022 Jan 1;11(1):e210073.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Graves' disease images
  • Differentials

    • Toxic nodular goitre
    • Painless and postnatal thyroiditis
    • Gestational hyperthyroidism
    More Differentials
  • Guidelines

    • Thyroid disease in pregnancy
    • Practice parameter for treatment of benign and malignant thyroid disease with I-131 sodium iodide
    More Guidelines
  • Patient information

    Graves’ disease

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer